Medical/Pharmaceuticals
CStone announces China's NMPA has accepted its new drug application for sugemalimab in the treatment of stage III NSCLC
* Sugemalimab becomes the world's first anti-PD-1/PD-L1 monoclonal antibody to significantly improve progression-free survival (PFS) in patients with stage III non-small cell lung cancer (NSCLC) without disease progression after concurrent or sequential chemoradiotherapy * The new drug applic...
2021-09-02 08:05
4839
Innovent and GenFleet Announce Exclusive Global License Agreement for GFH925 (KRAS G12C Inhibitor)
SAN FRANCISCO and SUZHOU, China, Sept. 2, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...
2021-09-02 08:00
6426
REPROCELL signs Strategic Collaboration Agreement with TEXCELL to boost its GMP iPSC - Master Cell Bank Manufacturing Service
YOKOHAMA, Japan, Sept. 2, 2021 /PRNewswire/ -- REPROCELL have signed a Strategic Collaboration Agreement with TEXCELLJAPAN, a TEXCELL Group Company, for GMP iPSC - Master Cell Banks (MCB) Manufacturing. The TEXCELL Group (hereinafter "TEXCELL") is a contract manufacturing organization (CMO) head...
2021-09-02 03:43
1973
Insilico Medicine Collaborates with Gray Matter to Fight Age-related Cognitive Decline
HONG KONG, Sept. 1, 2021 /PRNewswire/ -- Insilico Medicine is pleased to announce an R&D collaboration with Gray Matter, a longevity biotechnology company focused on peptide-based interventions against cognitive decline, age-related CNS diseases, and aging. This strategic partnership is intended ...
2021-09-01 22:08
4150
EmitBio Results Yield 99.99% Reduction of Delta in Human Tissue
New data proves technology neutralizes the Delta variant Third Human Trial Underway DURHAM, N.C., Sept. 1, 2021 /PRNewswire/ -- EmitBio, Inc., a life science company, today announced successful results from a new In Vitro Neutralization study of the Delta variant in human airway tissue. The stud...
2021-09-01 21:00
1883
EmitBio Results Yield 99.99% Reduction of Delta in Human Tissue
New data proves technology neutralizes the Delta variant Third Human Trial Underway DURHAM, N.C., Sept. 1, 2021 /PRNewswire/ -- EmitBio, Inc., a life science company, today announced successful results from a new In Vitro Neutralization study of the Delta variant in human airway tissue. The stud...
2021-09-01 21:00
2809
Seegene Receives CE-IVD Mark for Use of Combo Swab, a Self-Collection Device with Four COVID-19 Diagnostic Tests
SEOUL, South Korea, Sept. 1, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, announced on August 20 that it has obtained CE marking for the use of Combo Swab, a self-collection device with four diagnostic assays. Combo Swab is a user-friendly...
2021-09-01 17:40
2395
Hummingbird Bioscience Strengthens Leadership Team with Appointment of Josh House as Chief Financial Officer
HOUSTON and SINGAPORE, Sept. 1, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced the appointment of Josh House as Chief Financial Officer, effective immediately. Dr....
2021-09-01 17:00
1847
Harbour BioMed Announces IND Approval for Phase II Trial of Anti-FcRn Batoclimab in Chronic Inflammatory Demyelinating Polyneuropathy in China
CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Sept. 1, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) today announced that the Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) appl...
2021-09-01 13:05
3423
SK magic provides clean air and water to Malaysians at COVID-19 vaccine centers and hospitals
KUALA LUMPUR, Malaysia, Sept. 1, 2021 /PRNewswire/ -- In support of the National COVID-19 Immunisation Programme, SK magic, the leading home appliance company fromSouth Korea, equipped Covid-19 Vaccination Centres (CVCs) and treatment hospitals with its air and water purifiers to provide fresh and...
2021-09-01 11:49
3559
Zymo Research Receives CE Mark for New SafeCollect™ At-Home Sample Collection Kits
Self-collection devices designed for ease of use and safety IRVINE, Calif., Sept. 1, 2021 /PRNewswire/ -- Zymo Research announced today its new line of at-home sample collection kits has received CE marking for sale in the European Union (EU). TheSafeCollect™ Sample Collection Kits were designed...
2021-09-01 11:05
4126
SynForU(TM)-HerCare probiotics shows benefits to reduce vaginal yeast infection in pregnant women
KAOHSIUNG, Taiwan, Sept. 1, 2021 /PRNewswire/ -- The first clinical study which
has been published in the Journal of Applied Microbiology documents that
SynForU™-HerCare is effective in reducing vulvovaginal symptoms and recurrences
of vaginal candidiasis (VC) in pregnant women.
2021-09-01 09:00
6242
MedAlliance Announces First Patient Enrolled in the 3,300 Patient Landmark Sirolimus DEB vs DES Study
GENEVA, Sept. 1, 2021 /PRNewswire/ -- MedAlliance is pleased to announce the enrollment of the first patient in the ground-breaking coronary randomized controlled study "SELUTION DeNovo". This study utilizes SELUTION SLR™, a novel sirolimus drug-eluting balloon [DEB], versus a limus drug-eluting ...
2021-09-01 08:00
3129
European Stroke Organisation Conference (ESOC) 2021: Non-traditional risk factors for heart attack and stroke rising more steeply in women, major study reveals
BASEL, Switzerland, Sept. 1, 2021 /PRNewswire/ -- Work stress, sleep disorders, and fatigue, regarded as non-traditional risk factors for heart attack and stroke, are rising more steeply amongst women than men, according to a new study presented today at the European Stroke Organisation (ESO) Con...
2021-09-01 06:00
3233
Jacobio Announces Strategic Investment in Hebecell to Further Develop iPSC-NK Cell Therapy
BEIJING and SHANGHAI and BOSTON, Aug. 31, 2021 /PRNewswire/ -- Jacobio Pharmaceuticals ("Jacobio", 1167.HK) announced a strategic investment in the US-based biotech company Hebecell onAugust 31. Jacobio will collaborate with Hebecell to develop thenext-generation natural killer cell therapy based...
2021-08-31 22:05
6012
Jacobio Pharmaceuticals Announces 2021 Interim Results
BEIJING and SHANGHAI and BOSTON, Aug. 31, 2021 /PRNewswire/ -- Jacobio Pharmaceuticals ("Jacobio", 1167.HK) announced its results for the first half of 2021. Investment in R&D for the clinical-stage biotech firm reached175 million yuan (approx. US$27 million) for the half year, up 146 percent ye...
2021-08-31 22:01
6402
Alithea Genomics Launches BRB-Seq Kits for High-Throughput RNA-Seq of Tissue, Cells and Blood Samples
LAUSANNE, Switzerland, Aug. 31, 2021 /PRNewswire/ -- Alithea Genomics, a rapidly growing player in the transcriptomics field, has announced today the launch of its first MERCURIUS BRB-seq kits, which enable high-throughput and cost-efficient RNA-seq library preparation from a wide range of RNA sa...
2021-08-31 19:00
3496
CellCarta expands its biomarker capabilities for clinical trials by adding Olink technology to its global services
MONTRÉAL, Aug. 31, 2021 /PRNewswire/ -- CellCarta and Olink Proteomics AB
announced today a strategic collaboration to offerOlink® Target 96 & Target 48
to pharmaceutical and biotech customers, advancing targeted protein biomarker
quantification in clinical studies.
2021-08-31 19:00
3644
Senhwa's Silmitasertib, COVID-19 Drug Candidate, Receives Positive Interim Review from Data Monitoring Committee to Proceed
TAIPEI and SAN DIEGO, Aug. 31, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focused on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, today announced that its oral new drug, Silmitasertib, had received a positive feedbac...
2021-08-31 19:00
2185
Pharmaxis Treatment to Prevent Wound and Burns Scars Clears Phase 1 Trial
* Topical treatment safe and well tolerated in study of healthy volunteers * Full inhibition of lysyl oxidase enzymes achieved in skin with minimal systemic exposure * Collaboration with research team led by Professor Fiona Wood AM planning for trial in patients with established scars to com...
2021-08-31 18:00
2329
Week's Top Stories
Most Reposted
Klook and Mastercard collaborate to enhance travelers' experiences across Asia Pacific
[Picked up by 312 media titles]
2026-08-27 10:25
AIMX Singapore 2026 Accelerates AI Deployment Through Catalysing Industry Innovation and Advancing Global Collaborations
[Picked up by 304 media titles]
2026-08-24 10:00
Henox and Nexusguard Announce Strategic Alliance at BATIC 2026 to Power and Protect the Next Generation of Digital Infrastructure
[Picked up by 297 media titles]
2026-08-25 10:00OGA 2026 Positions Kuala Lumpur as the Regional Marketplace for Southeast Asia's Energy Growth
[Picked up by 291 media titles]
2026-08-24 15:42
Rewarding Meetings Begin At Hyatt Regency Kuala Lumpur At KL Midtown
[Picked up by 289 media titles]
2026-08-25 07:00
Most Read
LightInTheBox to Report Second Quarter 2026 Financial Results on Wednesday, August 26, 2026
2026-08-21 19:00
12710